Pauline Jen Ryan
Corporate Officer/Principal chez OCULAR THERAPEUTIX, INC.
Postes actifs de Pauline Jen Ryan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC. | Corporate Officer/Principal | - | - |
| Red Sky Partners LLC | Corporate Officer/Principal | 01/07/2014 | - |
Historique de carrière de Pauline Jen Ryan
Anciens postes connus de Pauline Jen Ryan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Verik Bio, Inc. | Directeur Général | 01/04/2012 | 01/11/2017 |
| PROTEOSTASIS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2007 | 01/08/2011 |
| IMMUNOGEN, INC. | Corporate Officer/Principal | 01/05/1999 | 26/07/2007 |
Formation de Pauline Jen Ryan
| Northwestern University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OCULAR THERAPEUTIX, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
| Red Sky Partners LLC | |
| Verik Bio, Inc. |
- Bourse
- Insiders
- Pauline Jen Ryan
- Expérience
